Free Trial

Context Therapeutics (CNTX) Stock Chart & Stock Price History

Context Therapeutics logo
$0.98 -0.04 (-3.92%)
(As of 05:26 PM ET)

Context Therapeutics Stock Price Performance

5 Day
Performance
-21.43%
1 Month
Performance
-31.04%
3 Month
Performance
-53.91%
6 Month
Performance
-55.62%
Year-To-Date
Performance
-15.17%
1 Year
Performance
-12.85%
Receive CNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CNTX Stock Chart for Monday, December, 23, 2024

Context Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
12/20/2024$1.09$1.02
-6.42%
$1.11$0.96339,733 shs$76.50 million
12/19/2024$1.22$1.09
-10.66%
$1.23$1.08264,155 shs$81.75 million
12/18/2024$1.29$1.22
-5.43%
$1.33$1.18164,067 shs$91.50 million
12/17/2024$1.36$1.29
-5.15%
$1.39$1.17342,625 shs$96.75 million
12/16/2024$1.39$1.36
-2.16%
$1.39$1.27361,481 shs$102.00 million
12/13/2024$1.44$1.39
-3.47%
$1.47$1.37239,182 shs$104.25 million
12/12/2024$1.50$1.44
-4.00%
$1.52$1.40352,018 shs$108.00 million
12/11/2024$1.56$1.50
-3.85%
$1.61$1.49230,239 shs$112.50 million
12/10/2024$1.50$1.56
+4.00%
$1.56$1.48180,542 shs$117.00 million
12/09/2024$1.50$1.50$1.53$1.49158,162 shs$112.50 million
12/06/2024$1.50$1.50$1.53$1.43188,295 shs$112.50 million
12/05/2024$1.51$1.50
-0.66%
$1.52$1.48166,157 shs$112.50 million
12/04/2024$1.51$1.51$1.57$1.4848,747 shs$113.25 million
12/03/2024$1.56$1.51
-3.21%
$1.56$1.49156,727 shs$113.25 million
12/02/2024$1.52$1.56
+2.63%
$1.65$1.4890,610 shs$117.00 million
11/29/2024$1.50$1.52
+1.33%
$1.55$1.5045,803 shs$114 million
11/28/2024$1.50$1.50$1.55$1.4770,644 shs$112.50 million
11/27/2024$1.47$1.50
+2.04%
$1.55$1.4770,644 shs$112.50 million
11/26/2024$1.46$1.47
+0.68%
$1.53$1.42161,402 shs$110.25 million
11/25/2024$1.39$1.46
+5.04%
$1.55$1.39331,550 shs$109.50 million
11/22/2024$1.50$1.39
-7.33%
$1.43$1.27790,017 shs$104.25 million


This page (NASDAQ:CNTX) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners